| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |